Core Scientific's BTC Sale: A $175M Liquidity Move and Its Price Impact

Core Scientific's recent BTC sale was a significant liquidity move. The company sold approximately 1,900 BTC in January for $175 million, implying an average price of about $92,100 per coin. This sale brought its remaining holdings down to around 630 BTC, with management stating it expects to sell most of its bitcoin reserves by the end of the first quarter.

This adds near-term selling pressure to a market already facing a liquidity squeeze. The sale is part of a broader industry trend, with peers like Riot Platforms and MARA Holdings also announcing plans to sell their bitcoin holdings recently. For a market trading around $67,000, this coordinated reduction in miner treasuries acts as a direct flow of supply, potentially capping rallies and increasing volatility.

The scale is notable. Selling over 1,900 BTC in a single month represents a substantial flow, especially for a company that had only held 256 BTC a year prior. This rapid de-risking, funded by the sale proceeds, signals a decisive pivot away from mining. The immediate impact is a reinforcement of the liquidity headwinds that analysts say are driving price weakness.

The Financial Rationale: Revenue Collapse and Capital Need

The urgency behind Core Scientific's BTC sale is rooted in a severe revenue collapse. Total revenue for 2025 fell 37.5% year-over-year to $319 million. This dramatic drop was driven by the mining business, where Q4 mining revenue fell to $42.2 million from $79.9 million a year earlier. The company is now pivoting decisively away from this struggling segment.

The pivot is a strategic reallocation of its massive data center footprint. Management is shifting its ~1.3 GW data center footprint and power capacity toward AI HPC colocation. The goal is to build a 1.5 gigawatt pipeline of leasable capacity, targeting higher-margin, recurring revenue streams. The sale of its bitcoin BTC-0.83% treasury provides the immediate liquidity needed to fund this infrastructure build-out and support the AI strategy.

This shift is gaining analyst traction. The stock has seen multiple upgrades, with the average price target now sitting at $24.54, implying over 55% upside. Analysts appear to be valuing the company's infrastructure pivot and execution on large contracts like its CoreWeave deal more than its declining mining operations. The BTC sale, therefore, is a necessary step to finance a new growth story.

Catalysts and Risks: Execution and Price Watch

The success of Core Scientific's liquidity play hinges on execution. The company's pivot to AI colocation is advancing, with ~350 MW of power already energized and a target to deliver ~590 MW by early 2027. This progress, anchored by the CoreWeave contract, is critical for converting its massive data center footprint into the recurring revenue needed to fund the transition. Any delay or cost overrun here would undermine the financial rationale for the BTC sale.

A key near-term risk is price. The company's remaining BTC holdings are now a smaller, more vulnerable position. A sustained break below the $62,300 support level could force further opportunistic sales at a loss, eroding the liquidity cushion. This creates a direct feedback loop: weak price action may necessitate more selling, which could pressure the price further.

The broader AI infrastructure boom is a powerful tailwind, with $270 billion+ in new foreign direct investment flowing into the sector. This validates Core Scientific's strategic shift and supports demand for its capacity. Yet it also intensifies competition for capital and power, raising the stakes for execution. The company must not only deliver on its contracts but also do so efficiently in a crowded market.